BAIBYS, a Tel Aviv, Israel-based startup that developed an autonomous system for selecting ideal sperm for fertility treatments, has raised $4.5 million in Series A funding.

Investors 

The round was led by Firstime Ventures, with participation from Japanese pharmaceutical giant ROHTO. This latest funding brings BAIBYS' total investment to $6.5 million. 

Founded in 2014, Firstime Ventures is a Tel Aviv-based venture capital firm dedicated to supporting companies that are shaping a sustainable and accessible future. Its investment areas include Climate Solutions, Precision Agriculture, and Digital Health. 

BAIBYS Use of Funds 

The company will use the funding to accelerate its R&D and market entry. 

About BAIBYS 

Founded in 2020 by Dr. Nino Guy Cassuto and Gal Golov, BAIBYS offers an autonomous sperm selection solution for In-Vitro Fertilization (IVF). Using advanced machine vision (MV) and AI, the technology analyzes live sperm cells in real time, evaluating their quality based on high-magnification morphological criteria. The system then employs robotics to autonomously select and collect the sperm with the highest fertilization potential, ready for microinjection in IVF procedures. 

Funding Details 

Company: BAIBYS™ Fertility Ltd. 

Raised: $4.5M 

Round: Series A 

Funding Date: August 2024 

Lead Investor: Firstime Ventures 

Additional Investors: ROHTO 

Company Website: https://www.baibys.com/ 

Software Category: Fertility

Source: https://www.calcalistech.com/ctechnews/article/hyu7zxgqa